R

Read Gene SA
WSE:RDG

Watchlist Manager
Read Gene SA
WSE:RDG
Watchlist
Price: 4.96 PLN -0.8% Market Closed
Market Cap: 58.5m PLN
Have any thoughts about
Read Gene SA?
Write Note

Read Gene SA
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Read Gene SA
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
R
Read Gene SA
WSE:RDG
Selling, General & Administrative
-zł4.8m
CAGR 3-Years
-43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mabion SA
WSE:MAB
Selling, General & Administrative
-zł53.5m
CAGR 3-Years
-42%
CAGR 5-Years
-26%
CAGR 10-Years
-29%
G
Genomed SA
WSE:GEN
Selling, General & Administrative
-zł7m
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
B
Bioton SA
WSE:BIO
Selling, General & Administrative
-zł70.2m
CAGR 3-Years
-3%
CAGR 5-Years
18%
CAGR 10-Years
6%
U
Urteste SA
WSE:URT
Selling, General & Administrative
-zł3.3m
CAGR 3-Years
-97%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Synthaverse SA
WSE:SVE
Selling, General & Administrative
-zł27.5m
CAGR 3-Years
-22%
CAGR 5-Years
-11%
CAGR 10-Years
-4%
No Stocks Found

Read Gene SA
Glance View

Market Cap
58.5m PLN
Industry
Biotechnology

Read-Gene SA engages in the medical research and testing. The company is headquartered in Szczecin, Woj. Zachodniopomorskie. The company went IPO on 2009-02-12. The company is focused on technologies which aim is to detect, prevent and treat malignant tumors. The firm specializes in three fields: chemoprevention, clinical trials and genetic testing. The company offers breast cancer, colon cancer and prostate cancer tests, as well as, medical consultancy, DNA tests and supplements. The firm operates one wholly owned subsidiary, Dieta Antyrakowa Read-Gene Sp. z o.o. Its major shareholder is GEN-PAT-MED Sp. z o.o.

RDG Intrinsic Value
2.52 PLN
Overvaluation 49%
Intrinsic Value
Price
R

See Also

What is Read Gene SA's Selling, General & Administrative?
Selling, General & Administrative
-4.8m PLN

Based on the financial report for Jun 30, 2024, Read Gene SA's Selling, General & Administrative amounts to -4.8m PLN.

What is Read Gene SA's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 3Y
-43%

Over the last year, the Selling, General & Administrative growth was -59%. The average annual Selling, General & Administrative growth rates for Read Gene SA have been -43% over the past three years .

Back to Top